Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-08 | New | $800,000 | $800,000 | Debt Only | 06b | SEC link |
| 2024-10-15 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2024-08-20 | New | $1,300,000 | $1,300,000 | Debt Only | 06b | SEC link |
| 2019-05-14 | New | $7,499,972 | $7,499,972 | Equity Only | 06b | SEC link |
| 2018-08-30 | New | $9,000,000 | $9,000,000 | Equity Only | 06b | SEC link |
| 2017-04-10 | New | $30,000,003 | $30,000,003 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Baltera | Director, Executive |
| Robert A Beardsley | Executive |
| Baltera Bob | Director, Executive |
| Jerry Callahan | Executive |
| Howard Dittrich | Executive |
| Daniel Estes | Director |
| Daniel Estes, Ph.D. | Director |
| Brian Farmer | Executive |
| Dennis Fenton, Ph.D. | Director |
| Michael Jandernoa | Director |
| Nilesh Kumar | Director |
| Nilesh Kumar, Ph.D. | Director |
| Mark Olesnavage | Executive |
| Elaine Sun | Director |
| David Van Andel | Director |
| Robert Zerbe | Director |
| Robert Zerbe, M.D. | Director |